🚀 VC round data is live in beta, check it out!
Hualan Biological Engineering Valuation Multiples
Discover revenue and EBITDA valuation multiples for Hualan Biological Engineering and similar public comparables like Livzon Pharmaceutical Group, Ipca Laboratories, Tianjin Pharma, NewAmsterdam Pharma and more.
Hualan Biological Engineering Overview
About Hualan Biological Engineering
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, recombinant proteins, and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin, and others. The vaccine products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine, and others. It also offers gene products such as Monoclonal Antibodies for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Founded
1992
HQ
Employees
4.0K
Website
Sectors
Financials (LTM)
EV
$4B
Hualan Biological Engineering Financials
Hualan Biological Engineering reported last 12-month revenue of $673M and EBITDA of $222M.
In the same LTM period, Hualan Biological Engineering generated $317M in gross profit, $222M in EBITDA, and $142M in net income.
Revenue (LTM)
Hualan Biological Engineering P&L
In the most recent fiscal year, Hualan Biological Engineering reported revenue of $674M and EBITDA of $214M.
Hualan Biological Engineering expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $673M | XXX | $674M | XXX | XXX | XXX |
| Gross Profit | $317M | XXX | $388M | XXX | XXX | XXX |
| Gross Margin | 47% | XXX | 58% | XXX | XXX | XXX |
| EBITDA | $222M | XXX | $214M | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | 32% | XXX | XXX | XXX |
| EBIT Margin | 27% | XXX | 27% | XXX | XXX | XXX |
| Net Profit | $142M | XXX | $138M | XXX | XXX | XXX |
| Net Margin | 21% | XXX | 20% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Hualan Biological Engineering Stock Performance
Hualan Biological Engineering has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
Hualan Biological Engineering's stock price is $2.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | 0.0% | XXX | XXX | XXX | $0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHualan Biological Engineering Valuation Multiples
Hualan Biological Engineering trades at 5.3x EV/Revenue multiple, and 16.2x EV/EBITDA.
EV / Revenue (LTM)
Hualan Biological Engineering Financial Valuation Multiples
As of April 19, 2026, Hualan Biological Engineering has market cap of $4B and EV of $4B.
Equity research analysts estimate Hualan Biological Engineering's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hualan Biological Engineering has a P/E ratio of 28.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 5.3x | XXX | 5.3x | XXX | XXX | XXX |
| EV/EBITDA | 16.2x | XXX | 16.8x | XXX | XXX | XXX |
| EV/EBIT | 19.9x | XXX | 19.8x | XXX | XXX | XXX |
| EV/Gross Profit | 11.3x | XXX | 9.3x | XXX | XXX | XXX |
| P/E | 28.3x | XXX | 29.2x | XXX | XXX | XXX |
| EV/FCF | 6.9x | XXX | 4.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hualan Biological Engineering Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Hualan Biological Engineering Margins & Growth Rates
Hualan Biological Engineering's revenue in the last 12 month grew by 5%.
Hualan Biological Engineering's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Hualan Biological Engineering's rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hualan Biological Engineering's rule of X is 42% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Hualan Biological Engineering Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 33% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 38% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 42% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 18% | XXX | 18% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | 5% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | 7% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 31% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Hualan Biological Engineering Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Hualan Biological Engineering | XXX | XXX | XXX | XXX | XXX | XXX |
| Livzon Pharmaceutical Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Ipca Laboratories | XXX | XXX | XXX | XXX | XXX | XXX |
| Tianjin Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| NewAmsterdam Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Indivior Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hualan Biological Engineering M&A Activity
Hualan Biological Engineering acquired XXX companies to date.
Last acquisition by Hualan Biological Engineering was on XXXXXXXX, XXXXX. Hualan Biological Engineering acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Hualan Biological Engineering
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHualan Biological Engineering Investment Activity
Hualan Biological Engineering invested in XXX companies to date.
Hualan Biological Engineering made its latest investment on XXXXXXXX, XXXXX. Hualan Biological Engineering invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Hualan Biological Engineering
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hualan Biological Engineering
| When was Hualan Biological Engineering founded? | Hualan Biological Engineering was founded in 1992. |
| Where is Hualan Biological Engineering headquartered? | Hualan Biological Engineering is headquartered in China. |
| How many employees does Hualan Biological Engineering have? | As of today, Hualan Biological Engineering has over 4K employees. |
| Is Hualan Biological Engineering publicly listed? | Yes, Hualan Biological Engineering is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Hualan Biological Engineering? | Hualan Biological Engineering trades under 002007 ticker. |
| When did Hualan Biological Engineering go public? | Hualan Biological Engineering went public in 2004. |
| Who are competitors of Hualan Biological Engineering? | Hualan Biological Engineering main competitors are Livzon Pharmaceutical Group, Ipca Laboratories, Tianjin Pharma, NewAmsterdam Pharma. |
| What is the current market cap of Hualan Biological Engineering? | Hualan Biological Engineering's current market cap is $4B. |
| What is the current revenue of Hualan Biological Engineering? | Hualan Biological Engineering's last 12 months revenue is $673M. |
| What is the current revenue growth of Hualan Biological Engineering? | Hualan Biological Engineering revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Hualan Biological Engineering? | Current revenue multiple of Hualan Biological Engineering is 5.3x. |
| Is Hualan Biological Engineering profitable? | Yes, Hualan Biological Engineering is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Hualan Biological Engineering? | Hualan Biological Engineering's last 12 months EBITDA is $222M. |
| What is Hualan Biological Engineering's EBITDA margin? | Hualan Biological Engineering's last 12 months EBITDA margin is 33%. |
| What is the current EV/EBITDA multiple of Hualan Biological Engineering? | Current EBITDA multiple of Hualan Biological Engineering is 16.2x. |
| What is the current FCF of Hualan Biological Engineering? | Hualan Biological Engineering's last 12 months FCF is $520M. |
| What is Hualan Biological Engineering's FCF margin? | Hualan Biological Engineering's last 12 months FCF margin is 77%. |
| What is the current EV/FCF multiple of Hualan Biological Engineering? | Current FCF multiple of Hualan Biological Engineering is 6.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.